Pharmacologic treatment of PTSD

Post-Traumatic Stress Disorder: Basic Science and Clinical Practice

Volumn , Issue , 2009, Pages 337-361

  Raskind, Murray A ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Antiadrenergic; anticonvulsant; antipsychotic; benzodiazepine; pharmacologic; PTSD; selective serotonin reuptake inhibitor

Indexed keywords

EID: 77953659140     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-329-9_16     Document Type: Chapter

References (111)

1. Kulka, R., Fairbank, J., Jordan, K. B., and Weiss, D. (1990) Trauma and the Vietnam War Generation: Report of Findings from the National Vietnam Veterans Readjustment Study. New York : Routledge.
2. Neylan, T. C., Marmar, C. R., Metzler, T. J., Weiss, D. S., Zatzick, D. F., Delucchi, K. L., et al. (1998) Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans. Am J Psychiatry 155 : 929-33.
3. Breslau, N., Davis, G. C., Andreski, P., and Peterson, E. (1991) Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 48 : 216-22.
4. Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., and Nelson, C. B. (1995) Posttraumatic stress disorder in the National Comorbidity Survey. A rch Gen Psychiatry 5 2: 1 048-6 0.
5. American Psychiatric Association. (2004) Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder. Washington, DC : American Psychiatric Press.
6. VA (Veterans Affairs), DoD (Department of Defense), Management of Post-Traumatic Stress Working Group. (2004) VA/DoD Clinical Practice Guideline for the Management of Posttraumatic stress. Version 1.0. Washington, DC : Department of Veterans Affairs and Department of Defense.
7. Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., and Farfel, G. M. (2007) Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs Setting. J Clin Psychiatry 68 : 711-20.
8. Mohamed, S., and Rosenheck, R. (2008) Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic-and symptom-guided drug selection. J Clin Psychiatry 69 : 959-65.
9. Institute of Medicine. (2008) Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC : National Academies Press.
10. Glavin, G. B. (1985) Stress and brain noradrenaline: a review. Behav Neurosci Rev 9 : 233-43.
11. Yehuda, R., Southwick, S., Giller, E. L., Ma, X., and Mason, J. W. (1992) Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis 180 : 321-25.
12. Geracioti, T. D., Jr., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., Jr., and Kasckow, J. W. (2001) CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 158 : 1227-30.
13. Liberzon, I., Abelson, J. L., Flagel, S. B., Raz, J., and Young, E. A. (1999) Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 21 : 40-50.
14. Mellman, T. A., Kumar, A., Kulick-Bell, R., Kumar, M., and Nolan, R. (1995) Nocturnal/ daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry 38 : 174-79.
15. McFall, M. E., Murburg, M. M., Ko, G. N., and Veith, R. C. (1990) Autonomic responses to stress in Vietnam combat veterans with posttraumatic stress disorder. Biol Psychiatry 27 : 1165-75.
16. Pitman, R. K., Orr, S. P., Forgue, D. F., deJong, J. B., and Claiborn, J. M. (1987) Psychophysiologic assessment of posttraumatic stress disorder in Vietnam combat veterans. Arch Gen Psychiatry 44 : 970-75.
17. Southwick, S. M., Krystal, J. H., Morgan, A., Johnson, D., Nagy, L. M., Nicolaou, A., Heninger, G. R., Charney, D. S. (1993) Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 50 : 266-74.
18. Reist, C., Duffy, J. G., Fujimoto, K., and Cahill, L. (2001) β-Adrenergic blockade and emotional memory in PTSD. Int J Neuropsychopharmacol 4 : 377-83.
19. Woodward, S. H., Arsenault, N. J., Murray, C., and Bliwise, D. L. (2000) Laboratory sleep correlates of nightmare complaint in PTSD inpatients. Biol Psychiatry 48 : 1081-87.
20. Mallick, B. N., Majumdar, S., Faisal, M., Yadav, V., Madan, V., and Pal, D. (2002) Role of norepinephrine in the regulation of rapid eye movement sleep. J Biosci 27 : 539-51.
21. Vythilingam, M., Anderson, G. M., Owens, M. J., Halaszynski, T. M., Bremner, J. D., Carpenter, L. L., Heninger, G. R., Nemeroff, C. B., and Charney, D. S. (2000) Cerebrospinal fluid corticotrophin-releasing hormone in healthy humans: effects of yohimbine and naloxone. J Clin Endocrinol Metab 85 : 4138-45.
22. Koob, G. F. (1999) Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46 : 1167-80.
23. Birnbaum, S., Gobeske, K. T., Auerbach, J., Taylor, J. R., and Arnsten, A. F. (1999) A role for norepinephrine in stress-induced cognitive deficits: alpha-1 adrenoreceptor mediations in the prefrontal cortex. Biol Psychiatry 46 : 1266-74.
24. Westfall, T. C., and Westfall, D. P. (2006) Adrenergic agonists and antagonists. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York : McGraw-Hill, pp. 237-95.
25. Cleland, J. G. (2003) β-Blockers for heart failure: why, which, when, and where. Med Clin North Am 87 : 339-71.
26. Cooper, K. L., McKiernan, J. M., and Kaplan, S. A. (1999) α-Adrenoreceptor antagonists in the treatment of benign prostatic hyperplasia. Drugs 57 : 9-17.
27. MacMillan, L. B., Hein, L., Smith, M. S., Piascik, M. T., and Limbird, L. E. (1996) Central hypotensive effects of the α 2A-adrenergic receptor subtype. Science 273 : 801-3.
28. Kinzie, J. D., and Leung, P. (1989) Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 177 : 546-50.
29. Kolb, L. C., Burris, B. C., and Griffiths, S. (1984) Propranolol and clonidine in the treatment of posttraumatic stress disorders of war. In: van der Kolk, B. A., ed., Posttraumatic Stress Disorder: Psychological and Biological Sequelae. Washington, DC : American Psychiatric Press, pp. 98-105.
30. Kinzie, J. D., Sacks, R. L., and Riley, C. M. (1994) The polysomnographic effects of clonidine on sleep disorders in posttraumatic stress disorders: a pilot study with Cambodian patients. J Nerv Ment Dis 182 : 585-87.
31. Neylan, T. C., Lenoci, M., Samuelson, K. W., Metzler, T. J., Henn-Haase, C., Hierholzer, R. W., Lindley, S. E., Otte, C., Schoenfeld, F. B., Yesavage, J. A., and Marmar, C. A. (2006) No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry 163 : 2186-88.
32. Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., and Keane, T. M. (1995) The development of a clinician administered PTSD scale. J Trauma Stress 8 : 75-90.
33. Davis, L. L., Ward, C., Rasmusson, A., Newell, J. M., Frazier, E., and Southwick, S. M. (2008) A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharm Bull 41 : 8-18.
34. Medical Economics Company. (2008) Physicians Desk Reference. 62nd ed. Montvale, NJ : Medical Economics.
35. Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., and Orr, S. P. (2002) Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51 : 189-92.
36. Stein, M. B., Kerridge, C., Dimsdale, J. E., and Hoyt, D. B. (2007) Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients. J Trauma Stress 20 : 923-32.
37. Menkes, D. B., Baraban, J. M., and Aghajanian, G. K. (1981) Prazosin selectively antagonizes neuronal responses mediated by alpha-1 adrenoreceptors in brain. Naunyn Schmiedebergs Arch Pharmacol 317 : 273-75.
38. Cecchi, M., Khoshbouei, H., Javors, M., and Morilak, D. A. (2002) Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine response to acute stress. Neuroscience 112 : 13-21.
39. Weathers, F. W., Litz, B. T., Herman, J. A., Huska, J. A., and Keane, T. M. (1993) The PTSD Checklist: reliability, validity, and diagnostic utility. Presented at the annual meeting of the International Society for Traumatic Stress Studies, San Antonio, TX, October 24-27.
40. Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K., Thomas, R. G., and McFall, M. E. (2003) Reduction in nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 160 : 371-73.
41. Guy, W. (1976) Assessment Manual for Psychopharmacology. Washington, DC : U.S. Department of Health, Education and Welfare. Publication (ADM) 76-338 NIMH, pp. 218-22.
42. Raskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., Shofer, J., O'Connell, J., Taylor, F., Gross, C., Rohde, K., and McFall, M. E. (2007) A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with posttraumatic stress disorder. Biol Psychiatry 61 : 928-34.
43. Taylor, F. B., Martin, P., Thompson, C., Williams, J., Mellman, T. A., Gross, C., Peskind, E. R., and Raskind, M. A. (2008) Prazosin effects on sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry 63 : 629-32.
44. Mellman, T. A., Knorr, B. R., Pigeon, W. R., Leiter, J. C., and Akay, M. (2004) Heart rate variability during sleep and the early development of posttraumatic stress disorder. Biol Psychiatry 55 : 953-56.
45. Baldessarini, R. J. (2006) Drug therapy of depression and anxiety disorders. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York : McGraw-Hill, pp. 429-59.
46. Baldessarini, R. J., and Tarazi, F. I. (2006) Pharmacotherapy of psychosis and mania. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York : McGraw-Hill, pp. 461-500.
47. American Diabetes Association. (2004) Consensus development conference on antipsychotic drugs and obesity in diabetes. Diabetes Care 27 : 596-601.
48. Rasmussen, D.A., Alexander, L.L., Raskind, M.A., and Froehlich, J.C. (Submitted). The α 1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcoholpreferring (P) rats. Alcoholism Clin Exp Res (In press).
49. Walker, B. M., Rasmussen, D. D., Raskind, M. A., and Koob, G. F. (2008) The effects of α 1-noradrenergic receptor antagonism on dependence-induced increases in responding for ethanol. Alcohol 42 : 91-97.
50. Simpson, T. L., Meredith, C. W., Gross, C. A., Raskind, M. A., and Saxon, A. J. (2007) Pilot trial of prazosin for treatment of alcohol dependence. Alcohol Clin Exp Res 31 (suppl): 60A.
51. Loscher, W. (1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanism of action. Prog Neurobiol 58 : 31-59.
52. Pollack, M. H., Roy-Byrne, P. P., Van Ameringen, M., et al. (2005) The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry 66 : 1401-8.
53. Herrero, A. I., Olmo, N., Gonzales-Escalada, J. R., et al. (2002) Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology 42 : 210-20.
54. Vaiva, G., Thomas, P., Ducrocq, F., Fontaine, M., Boss, V., Devos, P., Rascle, C., Cottencin, O., Brunet, A., Laffargue, P., and Goudemand, M. (2004) Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol Psychiatry 55 : 250-54.
55. Bremner, J. D., Innis, R. B., Southwick, S. M., Staib, L., Zoghbi, S., and Charney, D. S. (2000) Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 157 : 1120-26.
56. Geuze, E., van Berckel, B. N. M., Lammertsma, A. A., Boellard, R., de Kloet, C. S., Vermetten, E., and Westenberg, H. G. M. (2008) Reduced GABAA benzodiazepine receptor binding in veterans with posttraumatic stress disorder. Mol Psychiatry 13 : 74-83.
57. Fujita, M., Southwick, S. M., Denucci, C. C., Zoghbi, S. S., Dillon, M. S., Baldwin, R. M., et al. (2004) Central type benzodiazepine receptors in Gulf War veterans with posttraumatic stress disorder. Biol Psychiatry 56 : 95-100.
58. Post, R. M., Ballenger, J. C., Putnam, F. M., and Bunney, W. F. (1983) Carbamazepine in alcohol withdrawal syndromes. J Clin Psychopharmacol 3 : 204-5.
59. Davis, L. L., Davidson, J. R. T., Ward, C., Bartolucci, A., Bowden, C. L., and Petty, F. (2008) Divalproex in the treatment of posttraumatic stress disorder: a randomized, doubleblind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol 28 : 84-88.
60. Davidson, J. R. T., Brady, K., Mellman, T. A., Stein, M. B., and Pollack, M. H. (2007) The efficacy and tolerability of tiagabine in adult patients with posttraumatic stress disorder. J Clin Psychopharmacol 27 : 85-88.
61. Tucker, P., Trautman, R. P., Wyatt, D. B., Thompson, J., Wu, S.-C., Capece, J. A., and Rosenthal, N. R. (2007) Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68 : 201-6.
62. Davis, D., Kutcher, G. S., Jackson, E. I., and Mellman, T. A. (1999) Psychotic symptoms in combat-related posttraumatic stress disorder. J Clin Psychiatry 60 : 29-32.
63. Butterfield, M. I., Becker, M. E., Connor, K. M., Sutherland, S., Churchill, L. E., and Davidson, J. R. T. (2001) Olanzapine in the treatment of posttraumatic stress disorder: a pilot study. Int Clin Psychopharmacol 16 : 197-203.
64. Stein, M. B., Kline, N. A., and Matloff, J. L. (2002) Adjunctive olanzapine for SSRIresistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 159 : 1777-79.
65. Hamner, M. B., Faldowski, R. A., Ulmer, H. G., Frueh, B. C., Huber, M. G., and Arana, G. W. (2003). Adjunctive risperidone treatment in posttraumatic stress disorder: a preliminary controlled trial in effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 18 : 1-8.
66. Monnelly, E. P., Ciraulo, D. A., Knapp, C., and Keane, T. (2003) Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol 23 : 193-96.
67. Bartzokis, G., Lu, P. H., Turner, J., Mintz, J., and Saunders, C. S. (2004) Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry 57 : 474-79.
68. Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., Din, A. U., Wilson, D. R., Petty, F. (2006) Risperidone monotherapy for posttraumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol 21 : 275-80.
69. Reich, D. B., Winternitz, S., Hennen, J., Watts, T., and Stanculescu, C. (2004) A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry 65 : 1601-6.
70. Rothbaum, B. O., Killeen, T. K., Davidson, J. R. T., Brady, K. T., Connor, K. M., and Heekin, M. H. (2008) Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry February 13 : e1-e6, Epub ahead of print.
71. Robert, S., Hamner, M. B., Chose, S., et al. (2005) Quetiapine improves sleep disturbances in combat trauma veterans with PTSD: sleep data from a prospective open-label study. J Clin Psychopharmacol 25 : 387-88.
72. Medina, J. H., Novas, M. L., Wolfman, C. N., Levi de Stein, M., and De Robertis, E. (1983) Benzodiazepine receptors in rat cerebral cortex and hippocampus undergo rapid and reversible changes after acute stress. Neuroscience 9 : 331-35.
73. Charney, D. S., Mihic, S. J., and Harris, R. A. Hypnotics and sedatives. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York : McGraw-Hill, pp. 401-27.
74. Randall, P. K., Bremner, D., Krystal, J. H., Nagy, L. M., Heninger, G. R., Nicolau, A. L., and Charney, D. S. (1995) Effects of the benzodiazepine antagonist flumazenil in PTSD. Biol Psychiatry 38 : 319-24.
75. Braun, P. D., Greenberg, D., Dasberg, H., and Lerer, B. (1990) Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 51 : 236-38.
76. Gelpin, E., Bonne, O., Peri, T., Brandes, D., and Shalev, A. Y. (1996) Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 57 : 390-94.
77. Cates, M. E., Bishop, M. H., Davis, L. L., and Woolley, T. W. (2004) Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother 38 : 1395-99.
78. Davidson, J. R. T. (2004) Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. J Clin Psychiatry 65 (suppl 5) : 29-33.
79. Arora, R. C., Fichtner, C. G., O'Connor, F., and Crayton, J. W. (1993) Paroxetine binding in the blood platelets of posttraumatic stress disorder patients. Life Sci 53 : 919-28.
80. Southwick, S. M., Krystal, J. H., Bremner, D., Morgan, C. A., Nicolaou, A. L., Nagy, L. M., Johnson, D. R., Heninger, G. R., and Charney, D. S. (1997) Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 54 : 749-58.
81. Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., Farfel, G. M. (2002) Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA 283 : 1837-44.
82. Davidson, J. R.T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., and Farfel, G. M. (2001) Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58 : 485-92.
83. Marshall, R. D., Beebe, K. L., Oldham, M., and Zaninelli, R. (2001) Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 158 : 1982-88.
84. Tucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., and Pitts, C. D. (2001) Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 62 : 860-68.
85. Van der Kolk, B. A., Dreyfuss, D., Michaels, M., Shera, D., Berkowitz, R., Fisler, R., and Saxe, G. (1994) Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55 : 517-22.
86. Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S., and Davidson, J. R. T. (2000) Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 12 : 101-5.
87. Davidson, J. R., Book, S. W., Colket, J. T., Tupler, L. A., Roth, S., David, D., Hertzberg, M., Mellman, T., Beckham, J. C., Smith, R. D., Davison, R. M., Katz, R., and Feldman, M. E. (1997) Assessment of a new self-rating scale for posttraumatic stress disorder. Psychol Med 27 : 153-60.
88. Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., and Austin, C. (2002) Double-blind placebo-controlled study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychiatry 22 : 190-95.
89. Martenyi, F., and Soldatenkova, V. (2006) Fluoxetine in the acute treatment and relapse prevention of combat-related posttraumatic stress disorder: analysis of the veteran group of a placebo-controlled, randomized clinical trial. Eur Neuropsychopharmacol 16 : 340-49.
90. Montgomery, S. A., and Asberg, M. (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134 : 382-89.
91. Montgomery, S. A., and Asberg, M. (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134 : 382-89.
92. Davidson, J., Baldwin, D., Stein, D. J., Kuper, E., Benattia, I., Ahmed, S., Pedersen, R., and Musgnung, J. (2006) Treatment of posttraumatic stress disorder with venlafaxine extended release. Arch Gen Psychiatry 63 : 1158-65.
93. Davidson, J. R. T., Landerman, L. R., Farfel, G. M., and Clary, C. M. (2002) Characterizing the effects of sertraline in posttraumatic stress disorder. Psychol Med 32 : 661-70.
94. Meltzer-Brody, S., Connor, K. M., Churchill, E., and Davidson, J. R. T. (2000) Symptom-specific effects of fluoxetine in posttraumatic stress disorder. Int Clin Psychopharmacol 15 : 227-31.
95. Stein, D. J., Pederson, R., Rothbaum, B. O., Baldwin, D. S., Ahmed, S., Musgnung, J., and Davidson, J. (2008) Onset of activity and time to response on individual CAPSSX 17 items in patients treated for posttraumatic stress disorder with venlafaxine ER: a pooled analysis. Int J Neuropscychopharmacol 11 : 1-9.
96. Obendorfer, S., Saletu-Zyhlarz, G., and Saletu, B. (2000) Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Pharmacopsychiatry 42 : 69-81.
97. Hamilton, M. S., and Opler, L. A. (1992) Akathisia, suicidality, and fluoxetine. J Clin Psychiatry 53 : 401-6.
98. Shalev, A. (2007) A randomized controlled study of the efficacy of prolonged exposure, cognitive therapy and an SSRI in the prevention of PTSD. Presented at the 23rd International Society for Traumatic Stress Studies Annual Meeting, Baltimore, MD.
99. Davidson, J., Kudler, H., Smith, R., Mahorney, S. L., Lipper, S., Hammett, E., Saunders, W. B., and Cavenar, J. O. (1990) Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 47 : 259-66.
100. Kosten, T. R., Frank, J. B., Dan, E., McDougle, C. J., and Giller, E. L., Jr. (1991) Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179 : 366-70.
101. Schuckit, M., Robins, E., and Feighner, J. (1971) Tricyclic antidepressants and monoamine oxidase inhibitors. Arch Gen Psychiatry 24 : 509-14.
102. Hertzberg, M. A., Feldman, M. E., Beckham, J. C., and Davidson, J. R. T. (1996) Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 16 : 294-98.
103. Davis, L. L., Jewell, M. E., Ambrose, S., Farley, J., English, B., Bartolucci, A., and Petty, F. (2004) A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol 24 : 291-97.
104. Davidson, J. R., Weisler, R. H., Butterfield, M. I., Casat, C. D., Connor, M., Barnett, S., and van Meter, S. (2003) Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry 53 : 188-91.
105. Thompson, L. T., Moskal, J. R., and Disterhoft, J. F. (1992) Hippocampus-dependent learning facilitated by a monoclonal antibody or d-cycloserine. Nature 356 : 638-41.
106. Rothbaum, B. O. (2008) Critical parameters for d-cycloserine enhancement of cognitivebehavioral therapy for obsessive-compulsive disorder. Editorial. Am J Psychiatry 165 : 293-96.
107. Heresco-Levy, U., Kremer, I., Javitt, D. C., Goichman, R., Reshef, A., Blanaru, M., and Cohen, T. (2002) Pilot-controlled trial of d-cycloserine for the treatment of posttraumatic stress disorder. Int J Neuropsychopharmacol 5 : 301-7.
108. Bohus, B., Kovacs, G. L., and De Wied, D. (1978) Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes. Brain Res 157 : 414-17.
109. Pitman, R. K., Orr, S. P., and Lasko, N. B. (1993) Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res 48 : 107-17.
110. Jacobs-Rebhun, S., Schnurr, P. P., Friedman, M. J., Peck, R., Brophy, M., and Fuller, D. (2000) Posttraumatic stress disorder and sleep difficulty. Am J Psychiatry 157 : 1525-26.
111. Baker, D. G., West, S. A., Nicholson, W. E., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Bruce, A. B., Orth, D. N., Geracioti, T. D., Jr (1999) Serial CSF corticotrophin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 156 : 585-88.